Tioconazole

Chemical compound
  • D01AC07 (WHO) G01AF08 (WHO)
Legal statusLegal status
  • US: OTC
Identifiers
  • (RS)-1-[2-[(2-Chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
CAS Number
  • 65899-73-2 checkY
PubChem CID
  • 5482
DrugBank
  • DB01007 ☒N
ChemSpider
  • 5282 ☒N
UNII
  • S57Y5X1117
KEGG
  • D00890 checkY
ChEBI
  • CHEBI:9604 ☒N
ChEMBL
  • ChEMBL1200438 ☒N
CompTox Dashboard (EPA)
  • DTXSID3046619 Edit this at Wikidata
ECHA InfoCard100.059.958 Edit this at WikidataChemical and physical dataFormulaC16H13Cl3N2OSMolar mass387.70 g·mol−1ChiralityRacemic mixture ☒NcheckY (what is this?)  (verify)

Tioconazole is an antifungal medication of the imidazole class used to treat infections caused by a fungus or yeast. It is marketed under the brand names Trosyd and Gyno-Trosyd (Pfizer, now Johnson & Johnson). Tioconazole ointments serve to treat women's vaginal yeast infections.[1] They are available in one day doses, as opposed to the 7-day treatments commonly used in the past.

Tioconazole topical (skin) preparations are also available for ringworm, jock itch, athlete's foot, and tinea versicolor or "sun fungus".

It was patented in 1975 and approved for medical use in 1982.[2]

Side effects

Side effects of vaginal tioconazole may include temporary burning itching, or irritation of the vagina. Vaginal swelling or redness, difficulty or burning during urination, headache, abdominal pain, and upper respiratory tract infection have been reported by people using tioconazole.[3] These side effects may be only temporary, and do not normally interfere with the patient's comfort enough to outweigh the result.[citation needed]

Synthesis

Antimycotic imidazole derivative.

Tiaconazole synthesis:[4][5]

A displacement reaction between 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanol and 2-chloro-3-(chloromethyl)thiophene is performed.

References

  1. ^ Tioconazole, Mayo Clinic
  2. ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 503. ISBN 9783527607495.
  3. ^ "VAGISTAT-1 Print Label" (PDF). Food and Drug Administration. 6 February 1997. Retrieved 25 January 2021.
  4. ^ BE 841309, Gymer GE, issued 1976, assigned to Pfizer 
  5. ^ US 4062966, Gymer GE, issued 1977, assigned to Pfizer 
Wikimedia Commons has media related to Tioconazole.
  • v
  • t
  • e
Wall/
membrane
Ergosterol
inhibitors
Azoles (lanosterol 14α-
demethylase inhibitors)
Imidazoles
Triazoles
Thiazoles
Polyene antimycotics
(ergosterol binding)
Squalene monooxygenase
inhibitors
Allylamines
Benzylamines
Others
β-glucan synthase
inhibitors
Intracellular
Pyrimidine analogues/
thymidylate synthase inhibitors
Mitotic inhibitors
Aminoacyl tRNA synthetase inhibitors
Others
  • v
  • t
  • e
Antibiotics
Arsenic compounds
Quinoline derivatives
Organic acids
Sulfonamides
Antifungals
Imidazoles
Triazoles
Polyenes
Other
Other